Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar 14;2023(3):rjad144.
doi: 10.1093/jscr/rjad144. eCollection 2023 Mar.

Mixed metaplastic carcinoma of the breast: a case report

Affiliations
Case Reports

Mixed metaplastic carcinoma of the breast: a case report

Amelia Tower et al. J Surg Case Rep. .

Abstract

A 68 year-old woman with no significant medical history discovered a lump incidentally in her left breast. The patient's initial imaging revealed a 4.6-cm irregular mass at 11:00 categorized as a BI-RADS 5 as well as an enlarged axillary lymph node and an area of 2.5 cm of heterogeneous calcifications in the 3 o'clock position. The 4.6-cm lesion was revealed to be infiltrating ductal carcinoma with a squamous component, mixed metaplastic carcinoma, which was strongly ER (100+)/PR (100+) positive, HER-2/Neu negative on FISH. The 2.5-cm calcifications were ductal carcinoma in situ. The patient completed neoadjuvant chemotherapy, and had an excellent response. After further discussion, the patient elected for breast conservation therapy and underwent a left wireless localized partial mastectomy with a left axillary dissection. Surgical pathology revealed a near complete pathologic response with only 8-mm residual tumour as well as a negative conversion of the clipped axillary node.

Keywords: invasive ductal carcinoma; metaplastic breast carcinoma; squamous cell carcinoma.

PubMed Disclaimer

References

    1. Reddy TP, Rosato RR, Li X, Moulder S, Piwnica-Worms H, Chang JC. A Comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res. 2020;22, 22. - PMC - PubMed
    1. Thapa B, Arobelidze S, Clark BA, Xuefei J, Daw H, Cheng YC, et al. Metaplastic breast cancer: characteristics and survival outcomes. Cureus 2022;14:e28551. - PMC - PubMed
    1. Damera VV, Chowdhury Z, Tripathi M, Singh R, Verma RK, Jain M. Clinicopathologic features of metaplastic breast carcinoma: experience from a tertiary cancer center of North India. Cureus 2022;14:e28978. - PMC - PubMed
    1. Aydiner A, Sen F, Tambas M, Ciftci R, Eralp Y, Saip P, et al. Metaplastic breast carcinoma versus triple-negative breast cancer. Medicine 2015;94:e2341. - PMC - PubMed
    1. Lee H, Jung S-Y, Ro JY, Kwon Y, Sohn JH, Park IH, et al. Metaplastic breast cancer: clinicopathological features and its prognosis. J Clin Pathol 2012;65:441–6. - PubMed

Publication types